An Indianapolis woman has been sentenced to 16 years in federal prison for her involvement in fentanyl trafficking, according to the U.S. Drug Enforcement Administration—Indianapolis and the Acting U.S. Attorney for the Southern District of Indiana, in a case that highlights the nation’s ongoing opioid crisis.
Stacy Lamont Griffin, 33, faced serious consequences after pleading guilty to trafficking 40 grams or more of the synthetic opioid, according to the US Drug Enforcement Administration.
The court record detailed Griffin’s illicit activities from September 22, 2023, to April 18, 2024, during which she distributed a total of 298 grams of fentanyl across at least six separate transactions, even while on probation and in community corrections for a previous felony domestic battery conviction. This behavior demonstrates a continuous pattern of criminal activity that includes prior convictions for attempted robbery and domestic violence.
It was of particular concern that her fentanyl product contained xylazine on September 22, 2023, a veterinary sedative known to increase the risk of overdose. Acting U.S. Attorney Childress expressed adamantly the danger Griffin posed by stating, “Griffin’s decision to sell dangerous fentanyl while serving probation shows a blatant disregard for both the law and human life.”
Griffin, however, did not roam the streets unchecked for long, as the DEA swiftly brought her operation to an end, after which United States District Judge Sarah Evans Barker settled on the sentence that offered a stark warning to potential offenders. The action was a testament to the judicious partnership among U.S. law enforcement agencies in combating the fentanyl problem—as highlighted by Acting U.S. Attorney Childress’s nod to the swift actions by the DEA—and Assistant U.S. Attorney Patrick Gibson, who played a significant role in the prosecution, was likewise praised for his work on this difficult but critical case.
